The concentration of insulin-like growth factor-1 in pregnancies complicated by pregnancy-induced hypertension and/or intrauterine hypotrophy
, 23, 23, 3, 1
Abstract
Objectives: The aim of the study was to compare Insulin-like Growth Factor-1 (IGF-1)concentration in pregnancies complicated by pregnancy-induced hypertension and/or intrauterine hypotrophy, and its correlation with maternal pressure and umbilical artery pulsatility and resistance indices. Material and methods: 65 pairs pregnant-newborn were included to four groups: I — control, II — PIH, III — Hypotrophy, IV — PIH and Hypotrophy. In the study we analyzed cord blood IGF-1 concentration, newborns antropometry, umbilical artery pulsatility and resistance indices and maternal pressure before delivery. Results: The concentration of IGF-1 was the lowest in IV group of hypotrophic newborns from pregnancies complicated by pregnancy-induced hypertension. In this group of patients there was strong negative correlation between IGF-1 concentration and maternal systolic and diastolic pressure. Conclusions: There is a strong negative correlation between IGF-1 concentration and maternal systolic pressure in group of hypotrophic newborns from pregnancies complicated by pregnancy-induced hypertension.
Keywords: intrauterine growth restrictionpregnancy-induced hypertensioninsulin-like growth factor-1
References
- Xiong Xu, Buekens P, Pridjian G, et al. Pregnancy-induced hypertension and perinatal mortality. J Reprod Med. 2007; 52(5): 402–406.
- Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 2011; 37(5): 501–514.
- Ananth CV, Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiology. 2010; 21(1): 118–123.
- Kornacki J, Skrzypczak J. [Preeclampsia--two manifestations of the same disease]. Ginekol Pol. 2008; 79(6): 432–437.
- Heimrath J, Czekański A, Krawczenko A, et al. [The role of endothelium in the pathogenesis of pregnancy-induced hypertension]. Postepy Hig Med Dosw (Online). 2007; 61: 48–57.
- Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002; 9(3): 147–160.
- Figueras F, Caradeux J, Crispi F, et al. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol. 2018; 218(2S): S790–S802.e1.
- Sieroszewski P, Guzowski G. [Prognostic value of the uterine doppler velocimetry at 20-24 gestation weeks for PIH and IUGR development in pregnancy]. Ginekol Pol. 2005; 76(5): 348–357.
- Milio LA, Hu J, Douglas GC. Binding of insulin-like growth factor I to human trophoblast cells during differentiation in vitro. Placenta. 1994; 15(6): 641–651.
- Bach LA. Endothelial cells and the IGF system. J Mol Endocrinol. 2015; 54(1): R1–13.
- Tivesten A, Bollano E, Andersson I, et al. Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology. 2002; 143(11): 4235–4242.
- Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996; 98(4): 894–898.
- Halhali A, Díaz L, Barrera D, et al. Placental calcitriol synthesis and IGF-I levels in normal and preeclamptic pregnancies. J Steroid Biochem Mol Biol. 2014; 144 Pt A: 44–49.
- Olmos A, Díaz L, Avila E, et al. Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies. Growth Factors. 2013; 31(4): 123–129.
- Dubova EA, Pavlov KA, Lyapin VM, et al. Expression of insulin-like growth factors in the placenta in preeclampsia. Bull Exp Biol Med. 2014; 157(1): 103–107.
- Sifakis S, Akolekar R, Kappou D, et al. Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia. Prenat Diagn. 2010; 30(11): 1026–1031.
- Barker DJ. The fetal and infant origins of adult disease. BMJ. 1990; 301(6761): 1111.
- Styrud J, Eriksson UJ, Grill V, et al. Experimental intrauterine growth retardation in the rat causes a reduction of pancreatic B-cell mass, which persists into adulthood. Biol Neonate. 2005; 88(2): 122–128.
- Mohan R, Baumann D, Alejandro EUy. Fetal undernutrition, placental insufficiency, and pancreatic β-cell development programming in utero. Am J Physiol Regul Integr Comp Physiol. 2018; 315(5): R867–R878.
- Bertin E, Gangnerau MN, Bellon G, et al. Development of beta-cell mass in fetuses of rats deprived of protein and/or energy in last trimester of pregnancy. Am J Physiol Regul Integr Comp Physiol. 2002; 283(3): R623–R630.
- Jones CT, Lafeber HN, Roebuck MM. Studies on the growth of the fetal guinea pig. Changes in plasma hormone concentration during normal and abnormal growth. J Dev Physiol. 1984; 6(6): 461–472.
- Jones CT. 55Lafeber HN, 55Rolph TP, 55Parer JT. Studies on the growth of the fetalguineapig. The effects of nutritional manipulation on prenatal growth and plasma somatomedin activity and insulin-like growth factor concentrations. J DevPhysiol. 1990; 13(4): 189–197.
- Wikström AK, Stephansson O, Cnattingius S. Previous preeclampsia and risks of adverse outcomes in subsequent nonpreeclamptic pregnancies. Am J Obstet Gynecol. 2011; 204(2): 148.e1–148.e6.
